[go: up one dir, main page]

ES2067696T3 - Composiciones de liberacion sostenida para tratar la enfermedad periodontal. - Google Patents

Composiciones de liberacion sostenida para tratar la enfermedad periodontal.

Info

Publication number
ES2067696T3
ES2067696T3 ES90312249T ES90312249T ES2067696T3 ES 2067696 T3 ES2067696 T3 ES 2067696T3 ES 90312249 T ES90312249 T ES 90312249T ES 90312249 T ES90312249 T ES 90312249T ES 2067696 T3 ES2067696 T3 ES 2067696T3
Authority
ES
Spain
Prior art keywords
sustained release
periodontal disease
release compositions
treat periodontal
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90312249T
Other languages
English (en)
Inventor
Nalinkant Chunilal Damani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27031904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2067696(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of ES2067696T3 publication Critical patent/ES2067696T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

ESTA INVENCION SE REFIERE A COMPOSICIONES, DISPOSITIVOS Y METODOS PARA EL TRATAMIENTO DE ENFERMEDADES DE LA CAVIDAD ORAL EN HUMANOS Y ANIMALES INFERIORES, QUE UTILIZA COMPOSICIONES, DISPOSITIVOS POLILACTIDO-GLICOIDES PARA LA APLICACION DE MEDICINAS EN LA CAVIDAD ORAL.
ES90312249T 1989-11-17 1990-11-08 Composiciones de liberacion sostenida para tratar la enfermedad periodontal. Expired - Lifetime ES2067696T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43906689A 1989-11-17 1989-11-17
US07/573,604 US5198220A (en) 1989-11-17 1990-08-24 Sustained release compositions for treating periodontal disease

Publications (1)

Publication Number Publication Date
ES2067696T3 true ES2067696T3 (es) 1995-04-01

Family

ID=27031904

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90312249T Expired - Lifetime ES2067696T3 (es) 1989-11-17 1990-11-08 Composiciones de liberacion sostenida para tratar la enfermedad periodontal.

Country Status (14)

Country Link
US (1) US5198220A (es)
EP (1) EP0430474B1 (es)
JP (1) JP3051154B2 (es)
KR (1) KR0156917B1 (es)
AT (1) ATE118170T1 (es)
AU (1) AU648278B2 (es)
CA (1) CA2029046C (es)
DE (1) DE69016755T2 (es)
DK (1) DK0430474T3 (es)
ES (1) ES2067696T3 (es)
FI (1) FI98126C (es)
GR (1) GR3015027T3 (es)
IE (1) IE66371B1 (es)
NZ (1) NZ236113A (es)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309669B1 (en) * 1984-03-16 2001-10-30 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
AU2605592A (en) 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
FR2691360B1 (fr) * 1992-05-20 1995-06-30 3P Agence Conseil Compositions pharmaceutiques destinees en particulier au traitement des poches parondontales et procede de fabrication.
NZ247712A (en) * 1992-06-19 1995-04-27 Colgate Palmolive Co Oral composition comprising an anti-bacterial compound, a water-insoluble biodegradable polymer, and an organic solvent
US5922340A (en) * 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5242910A (en) * 1992-10-13 1993-09-07 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US6015844A (en) * 1993-03-22 2000-01-18 Johnson & Johnson Medical, Inc. Composite surgical material
US6001895A (en) * 1993-03-22 1999-12-14 Johnson & Johnson Medical, Inc. Composite surgical material
GB2280850B (en) * 1993-07-28 1997-07-30 Johnson & Johnson Medical Absorbable composite materials for use in the treatment of periodontal disease
US5447725A (en) * 1993-06-11 1995-09-05 The Procter & Gamble Company Methods for aiding periodontal tissue regeneration
JPH09503504A (ja) * 1993-10-01 1997-04-08 ザ、プロクター、エンド、ギャンブル、カンパニー 成人歯周炎の治療のためのアジトロマイシンの用途とこの用途のための局所組成物
US5639466A (en) * 1994-02-24 1997-06-17 Chronopol, Inc. Method for packaging foodstuffs
EP0758244B2 (en) 1994-05-06 2008-02-13 Pfizer Inc. Controlled-release dosage forms of azithromycin
JPH08113534A (ja) * 1994-10-17 1996-05-07 Ichiro Umeuchi 歯周病治療器具
US5612052A (en) * 1995-04-13 1997-03-18 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US6413539B1 (en) 1996-10-31 2002-07-02 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US6551610B2 (en) 1995-04-13 2003-04-22 Poly-Med, Inc. Multifaceted compositions for post-surgical adhesion prevention
CN1156961A (zh) 1995-06-09 1997-08-13 欧罗赛铁克股份有限公司 产生长效局部麻醉的制剂和方法
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
WO1997049391A1 (en) 1996-06-24 1997-12-31 Euro-Celtique, S.A. Methods for providing safe local anesthesia
US6046187A (en) 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
US20020111603A1 (en) 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
KR100508229B1 (ko) 1997-03-18 2005-08-17 선스타 가부시키가이샤 고체 입자 형성용 조성물
US5962006A (en) * 1997-06-17 1999-10-05 Atrix Laboratories, Inc. Polymer formulation for prevention of surgical adhesions
KR100367144B1 (ko) 1997-07-02 2003-01-14 유로-셀티크 소시에떼 아노뉨 관절과 체강(ｂｏｄｙ ｓｐａｃｅ)내에서 연장된 마취
US6846478B1 (en) 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
US7128927B1 (en) 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
US6245345B1 (en) 1998-07-07 2001-06-12 Atrix Laboratories, Inc. Filamentous porous films and methods for producing the same
US6179862B1 (en) 1998-08-14 2001-01-30 Incept Llc Methods and apparatus for in situ formation of hydrogels
US6632457B1 (en) 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
AU5560899A (en) * 1998-08-14 2000-03-06 Incept Llc Methods and apparatus for in situ formation of hydrogels
US6514534B1 (en) * 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
US6818018B1 (en) 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
US6605294B2 (en) * 1998-08-14 2003-08-12 Incept Llc Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
US6152943A (en) 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6565874B1 (en) * 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US8226598B2 (en) 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US6626870B1 (en) 2000-03-27 2003-09-30 Artix Laboratories, Inc. Stoppering method to maintain sterility
US6566144B1 (en) 2000-03-27 2003-05-20 Atrix Laboratories Cover plate for use in lyophilization
US8283135B2 (en) 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
PE20020102A1 (es) 2000-06-30 2002-03-06 Procter & Gamble Composicion topica oral que comprende un agente modulador de la respuesta del huesped frente a patogenos periodontales
AU2001271545A1 (en) * 2000-06-30 2002-01-14 The Procter And Gamble Company Promoting whole body health
US8470359B2 (en) 2000-11-13 2013-06-25 Qlt Usa, Inc. Sustained release polymer
US20030152637A1 (en) * 2001-01-25 2003-08-14 Mark Chasin Local anesthetic, and method of use
JP2003231622A (ja) * 2001-12-04 2003-08-19 Kao Corp 口腔用組成物
EP1572115B1 (en) * 2002-11-27 2015-01-21 Ampio Pharmaceuticals, Inc. Treatment of diseases and conditions mediated by increased phosphorylation
WO2005030083A2 (en) * 2003-09-25 2005-04-07 Dmi Biosciences Inc. Methods and products which utilize n-acyl-l-aspartic acid
US20050084551A1 (en) 2003-09-26 2005-04-21 Jensen Claude J. Morinda citrifolia-based oral care compositions and methods
US20050125015A1 (en) * 2003-12-04 2005-06-09 Mcnally-Heintzelman Karen M. Tissue-handling apparatus, system and method
US20050125033A1 (en) * 2003-12-04 2005-06-09 Mcnally-Heintzelman Karen M. Wound closure apparatus
PE20060489A1 (es) 2004-08-13 2006-06-19 Schering Plough Ltd Formulacion farmaceutica que comprende un antibiotico, un triazol y un corticosteroide
WO2007099398A2 (en) 2005-09-27 2007-09-07 Naturalite Benelux B.V. Methods and compositions for treatment of skin
US8916050B2 (en) * 2004-09-27 2014-12-23 Special Water Patents B.V. Methods and compositions for treatment of water
US7611494B2 (en) * 2005-02-08 2009-11-03 Confluent Surgical, Inc. Spray for fluent materials
AU2006275744A1 (en) * 2005-07-28 2007-02-08 Indiana University Research & Technology Corporation Niobium oxide compositions, nanostructures, bioactive forms and uses thereof
US20070178220A1 (en) * 2006-01-31 2007-08-02 Karlinsey Robert L Materials and methods for manufacturing amorphous tricalcium phosphate and metal oxide alloys of amorphous tricalcium phosphate and methods of using the same
KR20090066327A (ko) 2006-11-13 2009-06-23 더 프록터 앤드 갬블 캄파니 구강내 이상부위의 표지를 위한 제품 및 방법
US8298516B2 (en) * 2006-12-22 2012-10-30 Douglas Anderson Calculus dissolving dental composition and methods for using same
US20090088723A1 (en) * 2007-09-28 2009-04-02 Accessclosure, Inc. Apparatus and methods for treating pseudoaneurysms
CN102065752A (zh) * 2008-05-02 2011-05-18 宝洁公司 用于显示口腔中的病症的产品及方法
US8795637B2 (en) 2008-11-25 2014-08-05 The Procter & Gamble Company Oral care compositions with fused silica
EP2396070B1 (en) 2009-02-12 2024-12-04 Incept Llc Drug delivery through hydrogel plugs
DK3045043T3 (da) 2009-02-26 2020-08-03 Relmada Therapeutics Inc Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse
BRPI0924652B1 (pt) 2009-04-01 2016-11-22 Colgate Palmolive Co composição de dentifrício e uso de pelo menos um material
US8434489B2 (en) * 2009-10-23 2013-05-07 Conceptus, Inc. Contraceptive devices and methods
US20110104080A1 (en) 2009-11-03 2011-05-05 David Salloum Salloum Oral Compositions for Treatment of Dry Mouth
US20110104081A1 (en) 2009-11-03 2011-05-05 Douglas Craig Scott Oral Compositions for Treatment of Dry Mouth
MX343550B (es) 2010-04-01 2016-11-08 The Procter & Gamble Company * Control del mal olor en toda la boca con una combinacion de agentes antibacterianos y desodorizantes.
RU2012158245A (ru) 2010-07-19 2014-08-27 Дзе Проктер Энд Гэмбл Компани Композиции, содержащие производные эфирно-масличных соединений, и их применение в средствах личной гигиены
US20120076734A1 (en) * 2010-09-15 2012-03-29 Jacob Olson Radiopaque antibiotic dental paste and uses thereof
US8900557B2 (en) 2010-12-30 2014-12-02 Jr Chem, Llc Dental cleaning composition
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
EP3613413A1 (en) 2011-12-05 2020-02-26 Incept, LLC Medical organogel processes and compositions
US10123953B2 (en) 2012-06-21 2018-11-13 The Procter & Gamble Company Reduction of tooth staining derived from cationic antimicrobials
US20130344120A1 (en) 2012-06-21 2013-12-26 Douglas Craig Scott Mouth Rinse Emulsions
BR112015010146A2 (pt) 2012-11-05 2017-07-11 Procter & Gamble sílica precipitada tratada com calor
US9827082B2 (en) 2013-02-26 2017-11-28 Orthoaccel Technologies, Inc. Fluoride releasing bite plate
CA2908663A1 (en) 2013-04-10 2014-10-16 The Procter & Gamble Company Oral care compositions containing polyorganosilsesquioxane particles
CN105120959A (zh) 2013-04-10 2015-12-02 宝洁公司 包含聚有机倍半硅氧烷颗粒的口腔护理组合物
AU2014250971B2 (en) 2013-04-10 2016-07-21 The Procter & Gamble Company Oral care compositions containing polyorganosilsesquioxane particles
US9572212B2 (en) 2014-05-21 2017-02-14 Lumens Co., Ltd. LED lighting device using AC power supply
JP6833809B2 (ja) 2015-08-04 2021-02-24 アイエスピー インヴェストメンツ エルエルシー アミノ官能性ビニルアルコールエーテルから誘導されたポリマー、およびその用途
WO2017106467A1 (en) 2015-12-15 2017-06-22 Gontarz John A Oral care formulation and method for the removal of tartar and plaque from teeth
ES2944116T3 (es) 2017-12-20 2023-06-19 Firmenich & Cie Composiciones para el cuidado bucal
US11801209B2 (en) 2017-12-21 2023-10-31 Firmenich Sa Cooling and flavor boosting compositions
US11191709B2 (en) 2019-04-26 2021-12-07 The Procter & Gamble Company Reduction of tooth staining derived from cationic antimicrobials
WO2021102896A1 (en) 2019-11-29 2021-06-03 Givaudan Sa Organic compounds
WO2021174475A1 (en) 2020-03-05 2021-09-10 Givaudan Sa Organic compounds
GB202012170D0 (en) 2020-08-05 2020-09-16 Givaudan Sa Organic compounds
WO2022170519A1 (en) 2021-02-09 2022-08-18 Givaudan Sa Organic compounds
GB202105661D0 (en) 2021-04-21 2021-06-02 Givaudan Sa Organic compounds
GB202303792D0 (en) 2023-03-15 2023-04-26 Givaudan Sa Cosmetic composition

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3608057A (en) * 1967-10-03 1971-09-21 Amicon Corp Process for making contact lenses
US4017615A (en) * 1970-10-29 1977-04-12 Syntex Corporation Propylene carbonate ointment vehicle
US3867190A (en) * 1971-10-18 1975-02-18 American Cyanamid Co Reducing capillarity of polyglycolic acid sutures
US3736646A (en) * 1971-10-18 1973-06-05 American Cyanamid Co Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
US4048256A (en) * 1976-06-01 1977-09-13 American Cyanamid Company Normally-solid, bioabsorbable, hydrolyzable, polymeric reaction product
US4328204A (en) * 1977-03-02 1982-05-04 Ethicon, Inc. Absorbable polymer-drug compounds and method for making same
US4293539A (en) * 1979-09-12 1981-10-06 Eli Lilly And Company Controlled release formulations and method of treatment
US4454110A (en) * 1982-05-24 1984-06-12 Forsyth Dental Infirmary For Children Self-gelling liquid composition for topical application in the oral cavity
US4443430A (en) * 1982-11-16 1984-04-17 Ethicon, Inc. Synthetic absorbable hemostatic agent
US4685883A (en) * 1983-09-12 1987-08-11 Jernberg Gary R Local delivery of chemotherapeutic agents for the treatment of periodontal disease
GR80494B (en) * 1983-10-07 1985-02-04 Forsyth Dental Infirmary Intra-pocket drug delivery devices for treatment of periodontal diseases
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4670252A (en) * 1985-05-24 1987-06-02 The Procter & Gamble Company Treatment of oral diseases
US4624256A (en) * 1985-09-11 1986-11-25 Pfizer Hospital Products Group, Inc. Caprolactone polymers for suture coating
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
JPH0617300B2 (ja) * 1986-09-22 1994-03-09 サンスタ−株式会社 歯周疾患治療用組成物
DE3708916A1 (de) * 1987-03-19 1988-09-29 Boehringer Ingelheim Kg Verfahren zur reinigung resorbierbarer polyester
JPH0645535B2 (ja) * 1987-05-20 1994-06-15 サンスタ−株式会社 歯槽骨代謝治療用組成物
IL86802A0 (en) * 1987-06-30 1988-11-30 Vipont Pharma Drug delivery devices
US5005074A (en) * 1989-11-17 1991-04-02 Rca Licensing Corporation Adaptive multistandard video comb filter
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease

Also Published As

Publication number Publication date
KR0156917B1 (ko) 1998-11-16
CA2029046C (en) 1995-03-28
KR910009243A (ko) 1991-06-28
IE904147A1 (en) 1991-05-22
FI905683A0 (fi) 1990-11-16
JP3051154B2 (ja) 2000-06-12
FI905683L (fi) 1991-05-18
EP0430474A1 (en) 1991-06-05
GR3015027T3 (en) 1995-05-31
EP0430474B1 (en) 1995-02-08
ATE118170T1 (de) 1995-02-15
DK0430474T3 (da) 1995-04-03
NZ236113A (en) 1993-05-26
DE69016755T2 (de) 1995-09-21
FI98126C (fi) 1997-04-25
AU6667690A (en) 1991-05-23
JPH03271219A (ja) 1991-12-03
AU648278B2 (en) 1994-04-21
IE66371B1 (en) 1995-12-27
CA2029046A1 (en) 1991-05-18
FI98126B (fi) 1997-01-15
US5198220A (en) 1993-03-30
DE69016755D1 (de) 1995-03-23

Similar Documents

Publication Publication Date Title
ES2067696T3 (es) Composiciones de liberacion sostenida para tratar la enfermedad periodontal.
ES2099977T3 (es) Composiciones de liberacion prolongada para tratar enfermedades periodontales.
ES2082833T3 (es) Uso de monooleina en el tratamiento de la bolsa periodontal.
PA8484301A1 (es) Formulaciones farmaceuticas de liberacion controlada
AU6667790A (en) Sustained release compositions for treating periodontal disease
ATE80996T1 (de) Arzneimittel mit verzoegerter freisetzung.
ES2162319T3 (es) Uso del agente quelante clioquinol para la fabricacion de una composicion farmaceutica para el tratamiento de la enfermedad de alzheimer.
ES2068999T3 (es) Composiciones para la liberacion retardada de clorhexidina.
CO4290424A1 (es) Pirazolopiridinas, pirrolopiridinas, composiciones farmaceu- ticas que las contienen y procedimientos para su administra- cion como antagonista del factor de liberacion de cortico- tropina
AR003984A1 (es) Composiciones antipruriticas, cosmeticas y/o farmaceuticas, procedimiento para su preparacion y empleo de dichas composiciones para la obtencion de unmedicamento.
ES2182874T3 (es) Procedimiento de tratamiento de las uñas.
HN2000000268A (es) Compuestos , composiciones y metodos para estimular el crecimiento y elongacion de neuronas
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
ES2176296T3 (es) Composiciones farmaceuticas que permiten la liberacion prolongada de trimetacidina despues de la administracion por via oral.
BG105275A (en) Tan-1057 derivatives
ES2159357T3 (es) Derivados terpenoides (sarcodictinas) utiles como agentes antitumorales.
HN2001000214A (es) Alcanosulfonatos de fenoxifenilo
HN2001000204A (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
ES2188797T3 (es) Sales de n-(4-oxo-2-(1h-tetrazoil-5-il)-4h-1 benzopran-8-il)-4-(4-fenilbutoxi)benzamida.
GT199800062A (es) Utilizacion de derivados de tetrahidropiridina para la preparacion de medicamentos para el tratamiento delas enfermedades que provocan desmielinizacion.
ES2134171B1 (es) Composicion de plantas para eliminar el dolor de muelas y dientes producido por caries o flemones.
ECSP961893A (es) (metil sulfonil) fenil -2-(5h)- furanomas como inhibidores de cox - 2''
HN2002000271A (es) 2,5 diamidoindoles sustituidos y su utilizacion.
HN1998000114A (es) Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 430474

Country of ref document: ES